i n cm were 0.967 and 0.926 f o r respective o r a l and nares determinations, w i t h regression equations o f EL=6.7+0.226(HT) and EL= 5+0.252(HT).
a

A l l were symptomatic i n s p i t e o f therapy w i t h Azulfidine (14)
. steroids (1 1) and/or previous resections (6). A1 1 discontinued drugs once HPN was started. One needed subsequent steroids. 8 are i n remission from 45 t o 508 days a f t e r one HPN course. 6 relapsed w i t h i n 140 days o f the i n i t i a l course. 3 completed a 2nd course averaging 121 days, w i t h 2 relapsing w i t h i n 90 days and 1 i n remission t o 204 days. Of the 9 i n remission. only 5 are a t >5 months. 1, 3 and 2 respectively have completed an i n i t i a l , 2nd and 3rd course o f HPN. 1 required surgery f o r a r e c t a l f i s s u r e a f t e r an i n i t i a l 122 days o f HPN. A l l gained weight ( I l k kg average), had marked c l i n i c a l improvement and resumed peer group a c t i v i t i e s w h i l e on HPN. 9 demonstrated "catch up" growth and 4 others had appropriate height increases. Enteric p r o t e i n loss was reduced a f t e r HPN i n 2 o f 7 patients. Both are i n remission >5 months. Complications included catheter removal (1 per 432 days) f o r sepsis (2). dislodgement 2), subcutaneous leak ( I ) , thrombosis (1) and l o c a l i n f e c t i o n
Grand, Harvard Medical School, C h i l d r e n ' s Hosp. Med. C t r . , Boston, Mass. 02115 Cholestyramine (CH0L)is o f t e n used s u c c e s s f u l l y i n t h e t r e a tment of d i v e r s e d i a r r h e a l d i s o r d e r s , y e t i t s e f f e c t s on small i n t e s t i n a l mucosa have n o t been evaluated. Accordingly, r a t jejunal and i l e a l segments were s t u d i e d b e f o r e and a f t e r 3, 6 o r 12 days of t e s t d i e t c o n t a i n i n g 5% pure CHOL r e s i n i n powdered s t a n d a r d l a b chow. Weight g a i n during s t u d y was comparable i n both CHOL-fed and c o n t r o l groups. For j e j u n a l mucosa, t h e r e was no s i g n i f i c a n t d i f f e r e n c e i n wet weight o r t o t a l DNA c o n t e n t per segment, o r i n mucosal wet weight o r t o t a l p r o t e i n c o n t e n t p e r mg DNA i n any d i e t p e r i o d comparing CHOL-treated animals t o cont r o l s . S i m i l a r r e s u l t s were o b t a i n e d f o r i l e a l mucosa, e x c e p t , a t 1 2 days, mucosal wet weight p e r segment i n c r e a s e d (p<.05) i n t h e CHOL t r e a t e d r a t s . J e j u n a l d i s a c c h a r i d a s e s (U/gm p r o t e i n ) r o s e s i g n i f i c a n t l y a f t e r 12 days of CHOL(sucrase:control 74'10 v s CHOL-fed 102i5, pC.02; l a c t a s e : c o n t r o l 9.1t0.8 vs CHOL-fed 14.3'0.7, p<.001). Expressing t h e d a t a a s s p e c i f i c a c t i v i t y p e r segment o r p e r mg DNA gave s i m i l a r r e s u l t s . I l e a l d i s a c c h a r i d a s e d i d n o t change s i g n i f i c a n t l y . Conc1usions:CHOL feeding f o r 12 days does n o t i n f l u e n c e j e j u n a l mucosal mass (wet w e i g h t ) , c e l l ?umber (DNA c o n t e n t ) o r c e l l s i z e (mg protein/mg DNA) , and h a s s n l y a small e f f e c t on i l e a l mucosal mass. J e j u n a l d i s a c c h a r i d a s c o n t e n t (U/segment)rises d r a m a t i c a l l y a s does s p e c i f i c a c t i v i t y (U/mg p r o t e i n , U/mg DNA)suggesting e i t h e r a d i r e c t mucosal e f f e c >f CHOL o r an a l t e r a t i o n o f t h e i n t r a l u m i n a l phase s u f f i c i e n t t o )change brush border enzyme k i n e t i c s . t r a n s p o r t of i n t r a l u m i n a l a n t i g e n i n vivo. A s a model f o r inc t i v e BSA (as measured by t h e F a r r technique) i n serum compared o c o n t r o l s over 6 hours. Following h e a l i n g of t h e i n t e s t i n a l e s i o n , r a t s were s u b j e c t e d t o mild systemic anaphylaxis by i nravenous a d m i n i s t r a t i o n of worm antigen.
This treatment led t o han e s i n v a s c u l a r permeability a s measured by t h e accumulation f 1 5~I -r a t serum albumin i n t h e i n t e s t i n a l w a l l and s e c r e t i o n s . nduction of mild systemic anaphylaxis i n r a t s previously fed i t h BSA, r e s u l t e d i n marked enhancement of BSA uptake s u g g e s t i n N. P e t e r F . Whitinaton. sponsored by Gerard B . e l l ) . U n i v e r s i t y of Wisconsin School of Medicine. P e d i a t r i c s . Madison, Wisconsin. of 9 6 -b i l i r u b i n in i s o t o n i c bicarbonate buffered samster small bowel in vivo was performed in order t o c i d a t e t h e mechanism of t h e d i a r r h e a a s s o c i a t e d with photoherapy. Solutions of b i l i r u b i n , 0.125 t o 0.75mM. produced dose ependent s e c r e t i o n (negative net f l u x ) of Hz0 and ~a + ( t a b l e ) ; i m i l a r c o n c e n t r a t i o n s have been observed in t h e b i l e of t h e Gunn a t subjected t o phototherapy. At 0.5mM s i g n i f i c a n t p r o t e i n l o s s ccurred ( t a b l e ) but t h e r e was no biochemical evidence of s i g n i f i gnt e n t e r o c y t e i n j u r y a s measured by e f f l u e n t l o s s of DNA, laca s e and sucrase ( t a b l e ) o r post-perfusion mucosal a c t i v i t i e s of
